Once exclusively a treatment for diabetes, GLP-1 medications have gone mainstream — forcing restaurants to adjust to changing ...

Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study ...

This campaign uses that idea thoughtfully and meets people where they are consuming content while helping them feel ...

A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...

Tirzepatide doesn’t necessarily wear off after 5 days. The half-life of tirzepatide is 5 days, meaning the amount you have in ...

Your patient may be doing everything right but still not making progress. But there’s more to it than just A1c.

Adults with obesity and type 2 diabetes who underwent bariatric surgery had greater decreases in HbA1c and body weight than ...

Novo Nordisk’s new Ozempic ads star Justin Long and John Hodgman, the “Mac” and “PC” of an iconic Apple campaign, to promote the drug’s wider FDA approvals.

More than a decade ago, GLP-1 drugs began being marketed for weight loss. Sexenda was approved in the U.S. in 2014, and ...

Now, just months after these blockbuster weight-loss medications entered the Indian market, obstetricians and gynaecologists ...

A single-judge bench of Delhi high court had allowed Dr Reddy’s to continue manufacturing and exporting semaglutide to ...

A collaborative study from the MRC Laboratory of Medical Sciences (LMS) and Imperial College London has found that the protein ACE2 may play a ...